Genomic Vision is a molecular diagnostics and technology company specialized in the development of single DNA detection tools for research and in vitro diagnostics
Initially trained in Mathematics Applied to Social Sciences at the University of Paris Dauphine, Émilie Chataignier worked for 18 years in investment banking, from France with international partners.
As an analyst, trader and intermediary in the equity markets, she facilitated transactions and discussions between French-speaking institutional investors and US-listed companies. She has also been trained in mediation and commercial conflict management as well as interest-based negotiation and has been practicing since 2021 as a judicial and conventional mediator with large and small companies.
Emilie uses the communication tools of mediation and her network of investors, business leaders and experts, as well as her experience in risk analysis and value creation, to support business leaders in their governance, particularly during transitions. Convinced that power struggles are counterproductive in the long run, she ensures that the interests of all parties (the company, all members of the company, regulators, all industrial and financial partners) are respected.
It encourages creativity in the search for responsible and sustainable solutions, whether in prevention before entering into partnerships or in the amicable settlement of commercial and social disputes.